News from the healthcare data industry
January 04, 2023 08:40 AM Eastern Standard Time DURHAM, N.C.–(BUSINESS WIRE)–Duke Health is building upon its longstanding history of innovative research by joining with nference, a science-first software company, to...
nference’s new privacy-preserving nSights platform accelerates development of therapeutics and diagnostics for life sciences companies September 21, 2022 08:45 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, a science-first software company transforming...
Published in PNAS Nexus, this study has the ability to impact future research and inform more proactive and sustainable pandemic preparedness July 20, 2022 08:47 AM Eastern Daylight Time CAMBRIDGE,...
Novartis Pharmaceuticals Corporation to collaborate on development of new medical device software for earlier detection and intervention in cardiovascular disease July 13, 2022 08:47 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS...
Developed in collaboration with Janssen and Mayo Clinic, this technology has the potential to aid physicians in earlier detection of pulmonary hypertension, a progressive, life-threatening disease May 24, 2022 08:17 AM...
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
The ability to harness vast amounts of health data using advanced AI technology will lead to new discoveries and insights needed to improve patient care March 14, 2022 09:00 AM...
Results validate company’s methodology and provide insight about the rapid evolution of future variants of concern January 18, 2022 08:45 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–nference, an AI-driven health...
CAMBRIDGE, Mass., Dec. 15, 2021 /PRNewswire/ — nference, the AI-driven health technology company, announced today publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence (AI) software to...
CAMBRIDGE, Mass., Nov. 30, 2021 /PRNewswire/ — nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the...